HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells

Oncogene

Volumn 32, Issue 36, 2013, Pages 4222-4230

  Ma, G ^a   Yasunaga, J ^a   Fan, J ^a   Yanagawa, S ^a   Matsuoka, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

DAPLE; HBZ; HTLV 1; Tax; Wnt signaling pathway; Wnt5a

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BETA CATENIN; LEUCINE; LYMPHOID ENHANCER FACTOR 1; SHORT HAIRPIN RNA; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELETION MUTANT; DNA BINDING; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL; METASTASIS; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; T CELL LEUKEMIA; TWO HYBRID SYSTEM; WNT SIGNALING PATHWAY;

ADULT; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; VIRAL PROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84883742662     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.450     Document Type: Article

References (61)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480.
3. Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005; 2: 16.
4. Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005; 2: 17.
5. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7: 270-280.
6. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005; 24: 5976-5985.
7. Franchini G, Fukumoto R, Fullen JR. T-cell control by human T-cell leukemia/lymphoma virus type 1. Int J Hematol 2003; 78: 280-296.
8. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006; 103: 720-725.
9. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008; 112: 3788-3797.
10. Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 2011; 7: e1001274.
11. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
12. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 2005; 5: 21-30.
13. Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 2008; 8: 581-593.
14. McDonald SL, Silver A. The opposing roles of Wnt-5a in cancer. Br J Cancer 2009; 101: 209-214.
15. Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 2004; 39: 1683-1693.
16. Street A, Macdonald A, McCormick C, Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular betacatenin and stimulation of beta-catenin-responsive transcription. J Virol 2005; 79: 5006-5016.
17. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS et al. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 2003; 9: 300-306.
18. Shackelford J, Maier C, Pagano JS. Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc Natl Acad Sci USA 2003; 100: 15572-15576.
19. Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R et al. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 2005; 65: 6199-6206.
20. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 2004; 24: 2890-2904.
21. Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118-3123.
22. McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 1999; 96: 11464-11469.
23. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667.
24. Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M. ATF3 an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011; 8: 19.
25. Oshita A, Kishida S, Kobayashi H, Michiue T, Asahara T, Asashima M et al. Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway. Genes Cells 2003; 8: 1005-1017.
26. Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M et al. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood 2009; 113: 2755-2764.
27. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002; 76: 12813-12822.
28. Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 2007; 81: 1543-1553.
29. Clerc I, Polakowski N, Andre-Arpin C, Cook P, Barbeau B, Mesnard JM et al. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the downregulation of tax-dependent viral transcription by HBZ. J Biol Chem 2008; 283: 23903-23913.
30. Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R. The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev 1995; 9: 1087-1097.
31. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J 1991; 10: 123-132.
32. Travis A, Amsterdam A, Belanger C, Grosschedl R. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function (corrected). Genes Dev 1991; 5: 880-894.
33. Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB, ten Berge D, Nusse R et al. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 2008; 68: 6969-6977.
34. Roarty K, Serra R. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 2007; 134: 3929-3939.
35. Katoh M. Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int J Mol Med 2009; 23: 763-769.
36. Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T et al. HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator. Blood 2011; 118: 1865-1876.
37. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279-288.
38. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 2007; 282: 17259-17271.
39. Driessens G, Zheng Y, Locke F, Cannon JL, Gounari F, Gajewski TF. Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-gamma1 phosphorylation. J Immunol 2011; 186: 784-790.
40. Badiglian Filho L, Oshima CT, De Oliveira Lima F, De Oliveira Costa H, De Sousa Damiao R, Gomes TS et al. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol Rep 2009; 21: 313-320.
41. Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. Loss of betacatenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001; 145: 210-216.
42. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606-8614.
43. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L et al. WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 2008; 14: 5825-5832.
44. Klemm F, Bleckmann A, Siam L, Chuang HN, Rietkotter E, Behme D et al. Beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 2011; 32: 434-442.
45. Yamamoto H, Oue N, Sato A, Hasegawa Y, Matsubara A, Yasui W et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010; 29: 2036-2046.
46. Sukarawan W, Simmons D, Suggs C, Long K, Wright JT. WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors. Am J Pathol 2010; 176: 461-471.
47. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012; 21: 121-135.
48. Peloponese Jr JM, Yasunaga J, Kinjo T, Watashi K, Jeang KT. Peptidylproline cistrans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J Virol 2009; 83: 3238-3248.
49. Zhi H, Yang L, Kuo YL, Ho YK, Shih HM, Giam CZ. NF-kappaB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral antisense protein HBZ. PLoS Pathog 2011; 7: e1002025.
50. Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ et al. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood 2009; 113: 4016-4026.
51. Kuo YL, Giam CZ. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J 2006; 25: 1741-1752.
52. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y et al. Abundant tax protein expression in CD4\+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386-1392.
53. Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K et al. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009; 6: 19.
54. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002; 22: 1172-1183.
55. Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 1998; 3: 659-670.
56. Lee JS, Ishimoto A, Yanagawa S. Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem 1999; 274: 21464-21470.
57. Yanagawa S, Lee JS, Matsuda Y, Ishimoto A. Biochemical characterization of the Drosophila axin protein. FEBS Lett 2000; 474: 189-194.
58. Tezuka N, Brown AM, Yanagawa S. GRB10 binds to LRP6, the Wnt co-receptor and inhibits canonical Wnt signaling pathway. Biochem Biophys Res Commun 2007; 356: 648-654.
59. Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J Virol 2008; 82: 9928-9936.
60. Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 2004; 18: 1357-1363.
61. Fan J, Kodama E, Koh Y, Nakao M, Matsuoka M. Halogenated thymidine analogues restore the expression of silenced genes without demethylation. Cancer Res 2005; 65: 6927-6933.